|
1
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ta HT, Dass CR, Choong PF and Dunstan DE:
Osteosarcoma treatment: State of the art. Cancer Metastasis Rev.
28:247–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamashita N, Uchida Y, Ohshima T, Hirai S,
Nakamura F, Taniguchi M, Mikoshiba K, Honnorat J, Kolattukudy P,
Thomasset N, et al: Collapsin response mediator protein 1 mediates
reelin signaling in cortical neuronal migration. J Neurosci.
26:13357–13362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shih JY, Lee YC, Yang SC, Hong TM, Huang
CY and Yang PC: Collapsin response mediator protein-1: A novel
invasion-suppressor gene. Clin Exp Metastasis. 20:69–76. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shih JY, Yang SC, Hong TM, Yuan A, Chen
JJ, Yu CJ, Chang YL, Lee YC, Peck K, Wu CW and Yang PC: Collapsin
response mediator protein-1 and the invasion and metastasis of
cancer cells. J Natl Cancer Inst. 93:1392–1400. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan SH, Chao YC, Chen HY, Hung PF, Lin PY,
Lin CW, Chang YL, Wu CT, Lee YC, Yang SC, et al: Long form
collapsin response mediator protein-1 (LCRMP-1) expression is
associated with clinical outcome and lymph node metastasis in
non-small cell lung cancer patients. Lung Cancer. 67:93–100. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pan SH, Chao YC, Hung PF, Chen HY, Yang
SC, Chang YL, Wu CT, Chang CC, Wang WL, Chan WK, et al: The ability
of LCRMP-1 to promote cancer invasion by enhancing filopodia
formation is antagonized by CRMP-1. J Clin Invest. 121:3189–3205.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak and Schmittgen: Analysis of relative
gene expression data using real-time quantitative PCR and the
2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meyers PA and Gorlick R: Osteosarcoma.
Pediatr Clin North Am. 44:973–989. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang WL, Hong TM, Chang YL, Wu CT, Pan SH
and Yang PC: Phosphorylation of LCRMP-1 by GSK3β promotes filopoda
formation, migration and invasion abilities in lung cancer cells.
PLoS One. 7:e316892012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Klein MJ and Siegal GP: Osteosarcoma:
Anatomic and histologic variants. Am J Clin Pathol. 125:555–581.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harada S, Wei S and Siegal GP: Molecular
pathology of osteosarcoma. In: Bone Cancer. Primary Bone Cancers
and Bone Metastases. Heymann D: (2nd). Academic Press. (Cambridge,
MA). 213–222. 2014.
|
|
16
|
Tirino V, Paino F, Papaccio F, La Noce M,
Papaccio G and Desiderio V: Stemness markers of osteosarcoma. In:
Bone Cancer. Primary Bone Cancers and Bone Metastases. Heymann D:
(2nd). Academic Press. (Cambridge, MA). 205–211. 2014.
|
|
17
|
Meyers PA, Schwartz CL, Krailo M,
Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W,
Gebhardt M, Goorin AM, et al: Osteosarcoma: A randomized,
prospective trial of the addition of ifosfamide and/or muramyl
tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J
Clin Oncol. 23:2004–2011. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Janeway KA and Grier HE: Sequelae of
osteosarcoma medical therapy: A review of rare acute toxicities and
late effects. Lancet Oncol. 11:670–678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bryan RT and Tselepis C: Cadherin
switching and bladder cancer. J Urol. 184:423–431. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Patel S, Sumitra G, Koner BC and Saxena A:
Role of serum matrix metalloproteinase-2 and −9 to predict breast
cancer progression. Clin Biochem. 44:869–872. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Walkley CR: Modeling osteosarcoma: In
vitro and in vivo approaches. In: Bone Cancer. Primary
Bone Cancers and Bone Metastases. Heymann D: (2nd). Academic Press.
(Cambridge, MA). 195–204. 2014.
|
